US 8901169
Neprilysin inhibitors
granted A61KA61K31/192A61K31/197
Quick answer
US patent 8901169 (Neprilysin inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K31/192, A61K31/197, A61K31/341, A61K31/397